A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DRSP / Daily Record of Severity of Problems

[Related PubMed/MEDLINE]
Total Number of Papers: 51
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DRSP  (>> Co-occurring Abbreviation)
Long Form:   Daily Record of Severity of Problems
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome. ES, PMDD, PMS
2020 Biomarker validation of a new case definition of menstrual cycleassociated syndrome (MCAS) Opinion Paper. ACOG, MCAS
2020 Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. COC, DSRP, PMS
2020 Menstrual Cycle Characteristics and Premenstrual Syndrome Prevalence Based on the Daily Record of Severity of Problems in Korean Young Adult Women. PMS
2020 Study on urinary metabolomics of premenstrual dysphoric disorder patients with liver-qi depression syndrome treated with Xiaoyaosan: Study Protocol Clinical Trial (SPIRIT Compliant). LC-MS, PMDD
2020 The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones. AOPP, AREase, Hp, hs-CRP, LOOH, MC, MCAS, MDA, NOx, PMS, PON, TRAP
2020 The uterine-chemokine-brain axis: menstrual cycle-associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10. MCAS
2019 Lowered Plasma Steady-State Levels of Progesterone Combined With Declining Progesterone Levels During the Luteal Phase Predict Peri-Menstrual Syndrome and Its Major Subdomains. ACOG, PMS
2019 Thalamocortical dysconnectivity in premenstrual syndrome. fMRI, HCs, PFC, PMS
10  2019 The diagnosis of premenstrual mood disorders: Do we have it backwards? ---
11  2019 The menstrual cycle may not be limited to the endometrium but also may impact gut permeability. LPS
12  2018 A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. CAR, CBG, MEMS, PA, PAS, PMDD, PMS, PS, PSST
13  2018 Acupuncture and acupressure for premenstrual syndrome. CBM, CI, CNKI, ISPMD, MD, PMDD, PMS, RCT, RR, SSRIs
14  2018 Hippocampal fractional amplitude of low-frequency fluctuation and functional connectivity changes in premenstrual syndrome. EPI, fALFF, FC, HIPP, MCC, mPFC, OFC, PC, PCC, PMS, PMS
15  2018 Larger volume and different functional connectivity of the amygdala in women with premenstrual syndrome. ACC, FC, HC, mPFC, MRI, PMS
16  2018 Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. COC
17  2018 Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST). BMI, PABAK, PMDD, PMS, PRIME-MD, PSST
18  2018 Remote intervention using smartphone for rural women suffering from premenstrual syndrome: A propensity score matched analysis. CBT, PMS
19  2018 Semi-Individualized Homeopathy Add-On Versus Usual Care Only for Premenstrual Disorders: A Randomized, Controlled Feasibility Study. ITT, PP, UC
20  2017 Abnormal Spontaneous Brain Activity in Women with Premenstrual Syndrome Revealed by Regional Homogeneity. ACC, IFC, ITC, MFC, PMS, ReHo, rs-fMRI
21  2017 Altered fractional amplitude of low frequency fluctuation in premenstrual syndrome: A resting state fMRI study. ACC, fMRI, PMDD, PMS
22  2017 Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial. COC
23  2017 Cortisol awakening response is blunted and pain perception is increased during menses in cyclic women. CAR, STAI-T, VAS
24  2017 Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis. PMDD
25  2017 Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS). C-PASS, PMDD
26  2017 Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo. DRSP/EE, MADRS, OCP, PME
27  2017 Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial. GAMSA, PMDD
28  2016 Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome. PMDD, PMS
29  2015 Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. CGI, IDS-C, PMDD, PMTS, SRIs, SSRI
30  2014 Baduanjin exercise improved premenstrual syndrome symptoms in Macau women. PMS
31  2014 [Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 g in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study]. CGI, PMDD
32  2013 The role of anxiety sensitivity in the experience of menstrual-related symptoms reported via daily diary. AS, MDQ
33  2012 An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. DSR, OC, PMDD, PMS
34  2012 Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder. PMDD
35  2012 Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. PMDD, PMS
36  2011 Comparing the Effects of Echinophora-platyloba, Fennel and Placebo on Pre-menstrual Syndrome. PMS
37  2011 Ethinyl estradiol 20mug/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder. EE, PMDD
38  2010 Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. HRQoL, PMDD, PMS
39  2010 Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. PMDD, PMS, PSST, WPAI
40  2009 Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial. PMDD
41  2008 Frequency, intensity and impact of premenstrual syndrome in medical students. MCS, PCS, PMDD, PMS, SF36
42  2008 Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study. CGI, MINI, PMDD
43  2007 Differences in symptom scores and health outcomes in premenstrual syndrome. PMDD, PMS, SF-36
44  2007 Premenstrual dysphoric disorder--a neglected diagnosis? Preliminary study on a sample of Croatian students. PMDD
45  2007 Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. PMS
46  2006 Daily Record of Severity of Problems (DRSP): reliability and validity. PMDD
47  2005 Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. PMDD
48  2005 Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. PMDD
49  2005 Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. EE, OC, PMDD
50  2002 Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial. CGI, PGI, PLC, PMDD, PMTS-C
51  2000 Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. CGI-I, HAM-D, PMDD, Q-LES-Q, SAS